资讯

Adam Thomas has issued an update on his struggle with arthritis, telling his followers 'my life has completely changed'.
Psoriatic arthritis (PsA) is a chronic (long-term) condition that includes symptoms of arthritis and psoriasis. Arthritis is a joint condition that causes pain and inflammation, and psoriasis is a ...
Enthesitis is a key, but often overlooked, feature of psoriatic arthritis. Learn how this inflammation at tendon and ligament attachment sites can affect diagnosis, symptoms, and treatment.
People with psoriatic arthritis (PsA) often take medicines to help manage their condition and improve their symptoms ... This is not a complete list of medicines that may interact with Tremfya.
Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: A prospective, open-labelled, controlled pilot ...
Doctors typically diagnose psoriatic arthritis (PsA) using a variety of tests that help them rule out other causes of your symptoms. It may take multiple appointments to receive a diagnosis and ...
When it comes to living with psoriatic arthritis, eating a healthy, anti-inflammatory diet is often a part of a well-rounded management plan. Maintaining a healthy weight is also important, as ...
Bristol Myers Squibb's Sotyktu achieved promising phase 3 results in psoriatic arthritis, showcasing improved outcomes and extended efficacy. Read more here.
Key features discriminating between psoriatic and other arthropathies were ... who sought to modify the Moll and Wright criteria by adding a list of exclusion criteria to those proposed by Moll and ...
When diluted and gently applied, this traditional home remedy may help ease skin symptoms ... the redness and flakiness associated with psoriatic arthritis. ACV can help change the skin’s ...
Bristol Myers Squibb's Sotyktu achieved promising phase 3 results in psoriatic arthritis, showcasing improved outcomes and extended efficacy. Read more here. Skip to content ...
Bristol MyersBMY announced that the late-stage study on Sotyktu (deucravacitinib) in adults with active psoriatic arthritis ...